Review Article

Clinical Significance of PIK3CA Gene in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

Table 2

Associations of PIK3CA mutation with clinicopathological characteristics in non-small-cell lung cancer.

AuthorSex (M vs. F)Age (≥60 vs. <60)Lymph node metastasis (+ vs. -)TNM (advanced vs. limited)Smoking history (yes vs. no)

Ludovini [17]0.406 (0.077-2.148)0.709 (0.148-3.384)
Zhang [18]0.691 (0.333-1.434)2.823 (1.128-7.065)2.083 (0.890-4.877)1.109 (0.532-2.314)
Wang [21]
Vieira [22]
McGowan [23]1.080 (0.551-2.118)0.974 (0.399-2.378)
Song [24]1.341 (0.587-3.063)1.473 (0.654-3.321)0.962 (0.427-2.167)
Imperatori [25]
Wang [26]
Chang [27]
Aredo [28]
Overall ( (95% CI), ; , )1.07 (0.65-1.76), 0.789; 0.0, 0.4520.97 (0.56-1.67), 0.910; 45.8, 0.1741.25 (0.76-2.04), 0.375; 4.0, 0.3531.02 (0.53-1.99), 0.947; 0.0, 0.612

RR: relative risk; CI: confidence interval; M: male; F: female; TNM: tumor-node-metastasis.